"Albumin-Bound Paclitaxel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An injectable formulation of albumin-bound paclitaxel NANOPARTICLES.
Descriptor ID |
D000068196
|
MeSH Number(s) |
D02.455.426.392.368.242.888.777.500 D02.455.849.291.850.777.500 D12.776.034.073
|
Concept/Terms |
Albumin-Bound Paclitaxel- Albumin-Bound Paclitaxel
- Albumin Bound Paclitaxel
- Paclitaxel, Albumin-Bound
- Protein-Bound Paclitaxel
- Paclitaxel, Protein-Bound
- Protein Bound Paclitaxel
|
Below are MeSH descriptors whose meaning is more general than "Albumin-Bound Paclitaxel".
Below are MeSH descriptors whose meaning is more specific than "Albumin-Bound Paclitaxel".
This graph shows the total number of publications written about "Albumin-Bound Paclitaxel" by people in this website by year, and whether "Albumin-Bound Paclitaxel" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Albumin-Bound Paclitaxel" by people in Profiles.
-
Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer. Ann Surg. 2012 Jan; 255(1):140-6.
-
Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells. Neurochem Res. 2011 Dec; 36(12):2292-305.
-
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer. Clin Breast Cancer. 2010 Oct 01; 10(5):367-72.